文献速递脑血管病外科

遗传性出血性毛细血管扩张症患者脑动静脉畸形的外科治疗与内科治疗比较:一项回顾性多中心联盟研究

Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
PubMed 文献 · Neurosurgery · 2018-01-01

该回顾性多中心联盟研究比较了遗传性出血性毛细血管扩张症(HHT)患者脑动静脉畸形(AVM)手术切除与非手术治疗的功能结局。手术组19例患者共20个AVM,非手术组22例患者共33个AVM。随访期间手术组9%患者功能状态恶化,非手术组为16%(P > .05);末次随访时两组功能结局无统计学差异(P > .05)。作者认为手术切除的长期功能结局与非手术治疗(包括观察)相当,不良结局更少,可考虑作为多学科团队个体化治疗策略中的选择之一。

要点

  • HHT患者脑AVM手术组功能恶化9%,非手术组16%(P > .05)。
  • 末次随访两组功能结局无统计学差异(P > .05)。
  • 作者认为可考虑将手术切除作为HHT脑AVM个体化治疗选项。

核心结论

  • HHT患者脑AVM手术治疗的长期功能结局似乎与非手术治疗(包括观察)相当,且不良结局更少。
  • 作者认为可考虑将手术切除作为HHT脑AVM多学科团队个体化治疗策略中的管理选项。

研究设计与样本

  • 基于脑血管畸形联盟HHT项目数据库的回顾性多中心联盟研究。
  • 手术组(第1组)19例患者共20个切除的AVM,非手术组(第2组)22例患者共33个AVM。
  • 回顾性分析随访期间功能状态(改良Rankin量表评分)变化。

主要发现

  • 随访期间手术组9%患者功能状态恶化,非手术组为16%(P > .05)。
  • 末次随访时两组功能结局无统计学差异(P > .05)。

临床怎么用

  • 作者认为,对于HHT合并脑AVM患者,可考虑将手术切除作为多学科团队个体化治疗策略中的管理选项。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral arteriovenous malformations (AVMs) are common in patients with hereditary hemorrhagic telangiectasia (HHT). However, due to the rarity of HHT and little published evidence of outcomes from management of brain AVMs in this disease, current international HHT guidelines recommend an individualized approach. Specifically, the outcomes for surgical vs nonsurgical management of these lesions have not been reported to date. OBJECTIVE: To report long-term outcomes of surgical resection of brain AVMs in HHT patients compared to outcomes in nonsurgically treated patients. METHODS: From the database of the Brain Vascular Malformation Consortium HHT project, 19 patients with 20 resected AVMs (group 1) and 22 patients with 33 AVMs who received nonsurgical treatment (group 2) were studied. The groups were retrospectively reviewed for changes in functional status (modified Rankin Scale score) during the follow-up period. RESULTS: During the follow-up period, 9% of patients in group 1 suffered from worsening of functional status, whereas this figure was 16% for group 2 (P > .05). Functional outcomes were not statistically different between the 2 groups at the latest follow-up (P > .05). CONCLUSION: HHT patients treated surgically for brain AVMs appear to have long-term functional outcomes comparable to nonsurgical (including observational) therapy with fewer unfavorable outcomes. It is therefore reasonable to consider surgical resection as a management option in the multidisciplinary team's individualized treatment strategy for HHT patients with brain AVMs.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Meybodi AT, Kim H, Nelson J, et al. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study. Neurosurgery. 2018. PMID: 28973426. doi:10.1093/neuros/nyx168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。